Attributes for preference of new fast dissolving tablet (FDT) formulation of Ebastine in patients with allergy

被引：0
|
作者：
Roger, A
Fortea, J
Artes, M
Montilla, L
机构：
[1] Ctr Roger Barri Asmol & Allergia, Barcelona, Spain
[2] Labs Almirall SA, Barcelona, Spain
[3] Adelphi Targis SL, Barcelona, Spain
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67208-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [41] Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg):: A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults
    Antonijoan, Rosa
    Garcia-Gea, Consuelo
    Puntes, Montserrat
    Perez, Joselin
    Esbri, Ramon
    Serra, Cristina
    Fortea, Josep
    Barbanoj, Manuel J.
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 814 - 822
  • [42] Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
    Morris, Helen
    Marshall, Tracey
    Zakis, Katie
    Garfoot, Theresa
    Hayton, Conal
    Ortega, Pilar Rivera
    Leonard, Colm
    Blaikley, John
    Chaudhuri, Nazia
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] Renal function in patients with thalassemia major receiving Exjade® dispersible tablets and a new film-coated tablet formulation of deferasirox (Nanojade®)
    Falahati, Vahid
    Ghasemi, Ali
    Safari, Mohammad Reza
    Ghaffari, Kazem
    Yousefichaijan, Parsa
    Zamanian, Maryam
    ADVANCED BIOMEDICAL RESEARCH, 2022, 11 (01): : 84
  • [44] New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II ECLIPSE Study
    Taher, Ali T.
    Origa, Raffaella
    Perrotta, Silverio
    Kouraklis, Alexandra
    Ruffo, Giovan Battista
    Kattamis, Antonis
    Goh, Ai-Sim
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel Merino
    Porter, John B.
    BLOOD, 2016, 128 (22)
  • [45] New Film-Coated Tablet Formulation of Deferasirox is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II Eclipse Study
    Taher, Ali
    Origa, Raffaella
    Perrotta, Silverio
    Kouraklis, Alexandra
    Ruffo, Giovan
    Kattamis, Antonis
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel
    Porter, John
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S30 - S30
  • [46] Cost-utility of new film-coated tablet formulation of deferasirox vs deferoxamine among major beta-thalassemia patients in Iran
    Saiyarsarai, Parisa
    Khorasani, Elahe
    Photogeraphy, Hasti
    Ghaffari Darab, Mohsen
    Seyedifar, Meysam
    MEDICINE, 2020, 99 (28) : E20949
  • [47] NEW FILM-COATED TABLET FORMULATION OF DEFERASIROX IS WELL TOLERATED IN PATIENTS WITH THALASSEMIA OR MYELODYSPLASTIC SYNDROMES: RESULTS OF THE RANDOMIZED, PHASE II ECLIPSE STUDY
    Taher, Ali T.
    Origa, Raffaella
    Perrotta, Silverio
    Kouraklis, Alexandra
    Ruffo, Giovan Battista
    Kattamis, Antonis
    Goh, Ai-Sim
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel Merino
    Porter, John B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E346 - E346
  • [48] COST-UTILITY OF NEW FILM-COATED TABLET FORMULATION OF DEFERASIROX VERSUS DEFEROXAMINE AMONG MAJOR B-THALASSEMIA PATIENTS IN IRAN
    Khorasani, E.
    Darab, Ghaffari M.
    Seyedifar, M.
    VALUE IN HEALTH, 2018, 21 : S445 - S445
  • [49] New modified-release prednisone tablet formulation adapts drug release to circadian rhythms of symptoms and Interleukin-6 activity in patients with rheumatoid arthritis
    Buttgereit, F.
    Doering, G.
    Schaefler, A.
    Szechinski, J.
    Alten, R.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 9 - 9
  • [50] New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study
    Taher, Ali T.
    Origa, Raffaella
    Perrotta, Silverio
    Kourakli, Alexandra
    Ruffo, Giovan Battista
    Kattamis, Antonis
    Goh, Ai-Sim
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel Merino
    Porter, John B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (05) : 420 - 428
12345